Recent advances in glucose management are reshaping our understanding of cognitive decline and dementia prevention. Energy ...

In a groundbreaking study, a research team at KAIST has uncovered a gut-brain circuit that enables the brain to selectively ...

Loss of beta cell function serves as the basis for progression from normal glucose tolerance to impaired glucose tolerance, but insulin clearance may not be a major factor in the development of ...

On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated insulin delivery/AID system with Abbott’s future dual glucose-ketone sensor in the US.

Beta Bionics, Inc. has announced plans to integrate its iLet Bionic Pancreas automated insulin delivery system with Abbott’s upcoming dual glucose-ketone sensor in the United States.

Scientists have confirmed the existence of progenitor cells within the human pancreas that can be stimulated to develop into glucose-responsive beta cells. These significant findings open the door ...

ADA: Beta Bionics' automated insulin pump slashes glucose levels, diabetes distress in Type 1 patients By Andrea Park Jun 10, 2022 1:35pm ...

When the B6 production was turned off in first-responder cells in the pancreas of both zebrafish and mice, they found that the beta cells’ response to rising glucose levels was reduced. “This ...

Studying beta cells in lab rats whose blood glucose levels were slightly elevated, Gordon Weir, MD, senior investigator and senior staff physician, ...

On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated insulin delivery/AID system with Abbott’s future dual glucose-ketone sensor in the US.